chromic phosphate has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakshi, S; Barlow, JJ; Bender, MA; Lele, SB; Parthasarathy, KL; Piver, MS | 1 |
| Capek, V; Grady, EG; Karesh, SM; Mantravadi, RV; Pavel, DG; Spigos, DG | 1 |
| Blessing, J; Creasman, WT; Disaia, PJ; Johnston, W; Weed, JC; Wilkinson, RH | 1 |
| Abdel-Dayem, H; Collier, BD; Hamilton, K; Ozker, K; Pattillo, RA; Ruckert, AC; Wilson, C | 1 |
| Boccio, JR; Caro, RA; Lanari, E; Nicolini, JO; Ughetti, R; Zubillaga, MB | 2 |
| Aas, M; Andersson-Forsman, C; Garske, U; Glimelius, B; Lindgren, PG; Linné, T; Nilsson, S; Order, SE; Westlin, JE | 1 |
| Dempke, W; Firusian, N | 1 |
| Bakshi, S; Emrich, LJ; Lele, SB; Parthasarathy, KL; Piver, MS | 1 |
| Burrell, MO; Kirchner, AB; Powell, JL | 1 |
| Clarke-Pearson, DL; Creasman, WT; Johnston, WW; Soper, JT; Sullivan, DC; Vergadoro, F | 1 |
| Major, W; Neutze, J; Van Nostrand, D | 1 |
1 trial(s) available for chromic phosphate and Adenocarcinoma
| Article | Year |
|---|---|
An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chromium Compounds; Digestive System Neoplasms; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphates; Phosphorus Radioisotopes; Survival Rate | 1999 |
11 other study(ies) available for chromic phosphate and Adenocarcinoma
| Article | Year |
|---|---|
Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparoscopy; Middle Aged; Ovarian Neoplasms; Phosphates; Prognosis; Prospective Studies | 1982 |
Work in progress: intra-arterial P-32 chromic phosphate for prevention of postoperative liver metastases in high-risk colorectal cancer patients.
Topics: Adenocarcinoma; Chromium; Chromium Compounds; Colonic Neoplasms; Humans; Liver Neoplasms; Phosphates; Rectal Neoplasms; Risk | 1983 |
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Topics: Adenocarcinoma; Ascitic Fluid; Chromium; Chromium Compounds; Female; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1981 |
Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Topics: Adenocarcinoma; Cell Survival; Chromium Compounds; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Survival Rate; Tumor Cells, Cultured | 1995 |
Use of colloids of chromic [32P] phosphate in treatment of solid tumors.
Topics: Adenocarcinoma; Animals; Chromium Compounds; Colloids; Female; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Phosphates; Phosphorus Radioisotopes; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1996 |
Great particles [32P]chromic phosphate for treatment of solid tumors.
Topics: Adenocarcinoma; Animals; Chromium Compounds; Feces; Female; Injections; Mammary Neoplasms, Experimental; Phosphates; Rats; Rats, Sprague-Dawley; Remission Induction; Treatment Outcome; Urine | 1996 |
Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Chromium Compounds; Colloids; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Phosphates | 1997 |
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Time Factors | 1988 |
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Topics: Adenocarcinoma; Brachytherapy; Chromium; Chromium Compounds; Cystadenocarcinoma; Endometriosis; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes | 1987 |
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
Topics: Adenocarcinoma; Brachytherapy; Catheters, Indwelling; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Hysterectomy; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms | 1985 |
Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report.
Topics: Adenocarcinoma; Brachytherapy; Catheterization; Chromium; Chromium Compounds; Colonic Neoplasms; Female; Humans; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid | 1985 |